Single Escalating Dose Study Of HSK7653 In Healthy Subjects

NCT05983289 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM (Type 2 Diabetes Mellitus)

Interventions

DRUG: HSK7653
DRUG: Placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.